EUVIMEDEUVIMED entdecken
Crossref

Tibetan mesenchymal stem cell-derived exosomes alleviate pulmonary vascular remodeling in hypoxic pulmonary hypertension rats

Qingqing Zhang, Hong Liu, Chuanchuan Liu, Yuxiang Wang, Pan Huang, Xiaobo Wang, Yougang Ma, Lan Ma, Rili Ge iD

Stem Cells · 2024

DOI: 10.1093/stmcls/sxae032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells, 2024. Verfasst von Qingqing Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for High Altitude Medicine, Qinghai University, Xining 810001, People's Republic of China. Hauptthemen laut MEDLINE: Exosomes, Mesenchymal Stem Cells, Vascular Remodeling, Hypertension, Pulmonary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Qinghai Provincial Department of Science and Technology Project, Qinghai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxic pulmonary hypertension (HPH) is characterized by progressive pulmonary vasoconstriction, vascular remodeling, and right ventricular hypertrophy, causing right heart failure. This study aimed to investigate the therapeutic effects of exosomes from Tibetan umbilical cord mesenchymal stem cells on HPH via the TGF-β1/Smad2/3 pathway, comparing them with exosomes from Han Chinese individuals. An HPH rat model was established in vivo, and a hypoxia-induced injury in the rat pulmonary artery smooth muscle cells (rPASMCs) was simulated in vitro. Exosomes from human umbilical cord mesenchymal stem cells were administered to HPH model rats or added to cultured rPASMCs. The therapeutic effects of Tibetan-mesenchymal stem cell-derived exosomes (Tibetan-MSC-exo) and Han-mesenchymal stem cell-derived exosomes (Han-MSC-exo) on HPH were investigated through immunohistochemistry, western blotting, EdU, and Transwell assays. The results showed that Tibetan-MSC-exo significantly attenuated pulmonary vascular remodeling and right ventricular hypertrophy in HPH rats compared with Han-MSC-exo. Tibetan-MSC-exo demonstrated better inhibition of hypoxia-induced rPASMCs proliferation and migration. Transcriptome sequencing revealed upregulated genes (Nbl1, Id2, Smad6, and Ltbp1) related to the TGFβ pathway. Nbl1 knockdown enhanced hypoxia-induced rPASMCs proliferation and migration, reversing Tibetan-MSC-exo-induced downregulation of TGFβ1 and p-Smad2/3. Furthermore, TGFβ1 overexpression hindered the therapeutic effects of Tibetan-MSC-exo and Han-MSC-exo on hypoxic injury. These findings suggest that Tibetan-MSC-exo favors HPH treatment better than Han-MSC-exo, possibly through the modulation of the TGFβ1/Smad2/3 pathway via Nbl1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMesenchymal Stem CellsVascular RemodelingHypertension, PulmonaryHypoxiaAnimalsRatsRats, Sprague-DawleyMaleTibetHumansPulmonary ArteryTransforming Growth Factor beta1Cell ProliferationSignal TransductionDisease Models, AnimalSmad2 Protein

Stichwörter der Autor:innen

Han-MSC-exoNbl1TGFβ1Tibetan-MSC-exohypoxia pulmonary hypertension

Substanzen

Transforming Growth Factor beta1Smad2 Protein

Autor:innen und Institutionen

  • Research Center for High Altitude Medicine, Qinghai University, Xining 810001, People's Republic of China.
  • Key Laboratory of High Altitude Medicine (Ministry of Education), Xining 810001, People's Republic of China.
  • Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province (Qinghai-Utah Joint Research Key Lab for High Altitude Medicine), Qinghai University, Xining 810001, People's Republic…
  • Laboratory for High Altitude Medicine of Qinghai Province, Xining 810001, People's Republic of China.
  • Department of Respiratory and Critical Care Medicine, Qinghai University Affiliated Hospital, Xining 810001, People's Republic of China.

ORCID-Profile: Rili Ge

Förderung

  • National Natural Science Foundation of China
  • Qinghai Provincial Department of Science and Technology Project
  • Qinghai University

Zitieren

APA

Zhang, Q., Liu, H., Liu, C., Wang, Y., Huang, P., Wang, X., Ma, Y., Ma, L., & Ge, R. (2024). Tibetan mesenchymal stem cell-derived exosomes alleviate pulmonary vascular remodeling in hypoxic pulmonary hypertension rats. Stem Cells. https://doi.org/10.1093/stmcls/sxae032

Vancouver

Zhang Q, Liu H, Liu C, Wang Y, Huang P, Wang X, et al. Tibetan mesenchymal stem cell-derived exosomes alleviate pulmonary vascular remodeling in hypoxic pulmonary hypertension rats. Stem Cells. 2024. doi:10.1093/stmcls/sxae032

BibTeX
@article{Zhang2024,
  author = {Zhang, Qingqing and Liu, Hong and Liu, Chuanchuan and Wang, Yuxiang and Huang, Pan and Wang, Xiaobo and Ma, Yougang and Ma, Lan and Ge, Rili},
  title = {Tibetan mesenchymal stem cell-derived exosomes alleviate pulmonary vascular remodeling in hypoxic pulmonary hypertension rats},
  journal = {Stem Cells},
  year = {2024},
  doi = {10.1093/stmcls/sxae032}
}
Kostenlos starten →